University of Texas, Galveston
Also known as: Gulf Coast Heart Clinic, PLLC & University of Texas Medical Branch | Salehin, Salman | The University of Teas Medical Branch | The University of Texas Medical Branch | The University of Texas Medical Branch at Galveston | The University of Texas Medical Branch, Galveston | The University of Texas Medical Branch, Galveston, TX 77555 | The University of Texas Medical Branch (UTMB Health), Galveston, Texas. | University of Texas | University of Texas, Medical Branch | University of Texas Medical Branch at Galveston | University of Texas medical branch, Galveston | University of Texas Medical Branch - Galveston | University of Texas Medical Branch-Galveston | University of Texas Medical Branch, Galveston | University of Texas Medical Branch Galveston, TX 77555 | University of Texas Medical Branch in Galveston | University of Texas Medical Branch, Obstetrics/Gynecology, Route 0587, Galveston Texas USA, 77550-0587 | University of Texas Medical Branch, Shriners Hospitals for Children | University of Texas Medical Branch (UTMB) | University Texas Medical Branch | UT, Galveston | UTMB | U.T.M.B. | UTMB Galveston | UTMB-Galveston | UTMB, Galveston
Highest phase reached
Phase 4
First clinical trial
Oct 1, 1992Last known activity
Sep 4, 2026
Timeline
1890s
- Jan 1, 1891
University of Texas, Galveston— Founded
Drugs by trial phase (147 distinct, 138 trials)
Phase 4 (30 own, 0 via acquisition)
Phase 3 (35 own, 0 via acquisition)
Phase 2 (42 own, 0 via acquisition)
Phase 1 (28 own, 0 via acquisition)
Other trials (12 own, 0 via acquisition)
Indications
Studied for
- Achondroplasia
- Acquired Immunodeficiency Syndrome
- Adenocarcinoma
- Alcoholism
- Anemia
- Anemia, Iron-Deficiency
- Aspergillosis
- Asthma
- Ataxia
- Bile Duct Neoplasms
- Bone Diseases
- Brain Concussion
- Brain Injuries
- Brain Injuries, Traumatic
- Breast Neoplasms
- Bronchopulmonary Dysplasia
- Burns
- Cachexia
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Squamous Cell
- Cerebellar Ataxia
- Cholangiocarcinoma
- Cocaine-Related Disorders
- Cognitive Dysfunction
- Communicable Diseases
- Coproporphyria, Hereditary
- Depression
- Depressive Disorder
- Dermatitis
- Dermatitis, Atopic
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diarrhea
- Eclampsia
- Eczema
- Emergencies
- Enuresis
- Esophageal Neoplasms
- Fatigue
- Fatty Liver
- Fractures, Open
- Gallbladder Neoplasms
- Genital Neoplasms, Female
- Heart Failure
- HIV Infections
- Hyperglycemia
- Hyperplasia
- Hypertension
- Hypertension, Pregnancy-Induced
- Hypertension, Pulmonary
- Hypogonadism
- Infarction
- Infections
- Inflammation
- Influenza, Human
- Insulin Resistance
- Intestinal Neoplasms
- Irritable Bowel Syndrome
- Kidney Diseases
- Lung Diseases
- Lung Neoplasms
- Lymphedema
- Major Depressive Disorder
- Metabolic Syndrome
- Morning Sickness
- Multiple Organ Failure
- Myocardial Infarction
- Myocardial Reperfusion Injury
- Nausea
- Neoplasms
- Non-alcoholic Fatty Liver Disease
- Obesity
- Obstetric Labor Complications
- Pancreatic Neoplasms
- Papilloma
- Pituitary Diseases
- Porphyria, Acute Intermittent
- Porphyria Cutanea Tarda
- Porphyria, Erythropoietic
- Porphyrias
- Porphyrias, Hepatic
- Porphyria, Variegate
- Pre-Eclampsia
- Premature Birth
- Premature Rupture of Fetal Membranes
- Renal Insufficiency, Chronic
- Reperfusion Injury
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Rhinitis
- Rhinitis, Allergic
- Rupture
- Sarcopenia
- Shoulder Impingement Syndrome
- Sinusitis
- Spinal Cord Injuries
- Stomach Neoplasms
- Surgical Wound
- Surgical Wound Dehiscence
Recent trials (50)
- NCT07107659CollaboratorEarly Phase 1Sep 4, 2026
- NCT07294118Lead sponsorPhase 2Dec 31, 2025
- NCT07294118OfficialPhase 2Dec 31, 2025
- NCT06907199CollaboratorPhase 1Dec 1, 2025
- NCT06965621CollaboratorPhase 2Nov 30, 2025
- NCT07220473OfficialPhase 2Nov 30, 2025
- NCT07220473Lead sponsorPhase 2Nov 30, 2025
- NCT06794229OfficialPhase 2Nov 30, 2025
- NCT06794229CollaboratorPhase 2Nov 30, 2025
- NCT07203287OfficialPhase 4Aug 26, 2025
- NCT07203287Lead sponsorPhase 4Aug 26, 2025
- NCT06799013CollaboratorPhase 1Jul 10, 2025
- NCT06800092OfficialPhase 2/Phase 3Feb 15, 2025
- NCT06800092Lead sponsorPhase 2/Phase 3Feb 15, 2025
- NCT06395506OfficialN/AOct 29, 2024
Details
- Founded
- Galveston, TX, US Jan 1, 1891
- Last known activity
- Sep 4, 2026